RoXsta™ Oxidative Stress Diagnostic
Male fertility assessment
Phase 2Active
Key Facts
About Memphasys
Australian‑based MedTech firm delivering electrophoretic sperm‑separation and oxidative‑stress diagnostics for human and animal fertility markets.
View full company profileTherapeutic Areas
Other Male fertility assessment Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Male Fertility Diagnostic | Arex Life Sciences | Research/Development |
| AI Semen Analysis | illumicell AI | Development |